The Kyoto guidelines are a classification system for intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs). They were first published in 2006, and revised guidelines were published in 2012 1, 2017 3, and 2024 4. They have been previously known as the Sendai criter...